Adalimumab 80mg weekly dose escalation for hidradenitis suppurativa: A multi-centre retrospective cohort study incorporating therapeutic drug monitoring
Wainman, Hannah E Chua, Ser Ling O'Kane, Donal Mehrtens, Sarah Ingram, John R
Wainman, Hannah E
Chua, Ser Ling
O'Kane, Donal
Mehrtens, Sarah
Ingram, John R
Abstract
No abstract available.
MIDER Authors
Affiliations
Date
2026-01-28
Type
Journal Article
Subject
Collections
Citation
Wainman HE, Chua SL, O'Kane D, Mehrtens S, Ingram JR. Adalimumab 80 mg weekly dose escalation for hidradenitis suppurativa: a multicentre retrospective cohort study incorporating therapeutic drug monitoring. Clin Exp Dermatol. 2026 May 26;51(6):1104-1106. doi: 10.1093/ced/llag044.